www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Sigma_aldrich Logo
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > CAS Search > 1110813-31-4
english deutsch español

Suppliers for CAS

1110813-31-4

Properties

CAS   1110813-31-4 
Formula   C24H25ClFN5O2 

Structure

15 Registered suppliers

Amadis Chemical Company Limited P.R.China
rd Dacomitinib   CD details
Dayang Chem (Hangzhou) Co.,Ltd. P.R.China
rd Dacomitinib  

More details are to be found here
H&Z Industry Co.,Ltd P.R.China
rd Dacomitinib  

More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
rd Dacomitinib  

More details are to be found here
Capot Chemical Co., Ltd. P.R.China
rd Dacomitinib   CD details
Leap Chem Co., Ltd P.R.China
rd Dacomitinib   CD details
Shandong Ench Chemical Co.,Ltd P.R.China
rd Dacomitinib   CD details
Aea.ltd P.R.China
rd PF299  
Appearance   white powder
Purity   99% min

rd PF299804  
Appearance   white powder
Purity   99% min

rd Dacomitinib  
Appearance   white powder
Purity   99% min

Hangzhou Zhongqi Chem Co., Ltd P.R.China
rd Dacomitinib  
Appearance   white powder
Purity   99% min

BOC Sciences USA
rd Dacomitinib   CD details
Shandong SanYoung Industry Co., Ltd P.R.China
rd Dacomitinib  
Description :
Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types.
  • Molecular Weight :469.945
Molecular Formula :
C24H25ClFN5O2
Canonical SMILES :
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
InChI :
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey :
LVXJQMNHJWSHET-AATRIKPKSA-N
Appearance :
White to off-white solid powder
Synonyms :
dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299
More details are to be found here
AK Scientific, Inc. USA
rd Dacomitinib  
Description :
Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types.
  • Molecular Weight :469.945
Molecular Formula :
C24H25ClFN5O2
Canonical SMILES :
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
InChI :
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey :
LVXJQMNHJWSHET-AATRIKPKSA-N
Appearance :
White to off-white solid powder
Synonyms :
dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299
More details are to be found here
Chemos GmbH & Co. KG Germany
rd PF299804  
Description :
Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types.
  • Molecular Weight :469.945
Molecular Formula :
C24H25ClFN5O2
Canonical SMILES :
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
InChI :
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey :
LVXJQMNHJWSHET-AATRIKPKSA-N
Appearance :
White to off-white solid powder
Synonyms :
dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299
More details are to be found here
Chemtour Biotech Co., Ltd P.R.China
rd Dacomitinib  
Description :
Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types.
  • Molecular Weight :469.945
Molecular Formula :
C24H25ClFN5O2
Canonical SMILES :
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
InChI :
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey :
LVXJQMNHJWSHET-AATRIKPKSA-N
Appearance :
White to off-white solid powder
Synonyms :
dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
rd Dacomitinib  
Description :
Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types.
  • Molecular Weight :469.945
Molecular Formula :
C24H25ClFN5O2
Canonical SMILES :
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
InChI :
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey :
LVXJQMNHJWSHET-AATRIKPKSA-N
Appearance :
White to off-white solid powder
Synonyms :
dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299
More details are to be found here
Detailed information on the suppliers of
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved